AI assistant
Sending…
INTUITIVE SURGICAL INC — Director's Dealing 2024
Dec 2, 2024
29809_dirs_2024-12-02_b6290a29-12cf-4844-8f84-5824aa8bb245.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INTUITIVE SURGICAL INC (ISRG)
CIK: 0001035267
Period of Report: 2024-11-29
Reporting Person: DeSantis Robert (EVP & Chief Strategy & Corp Op)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-11-29 | Common Stock | M | 188 | $290.33 | Acquired | 5694 | Direct |
| 2024-11-29 | Common Stock | S | 188 | $539.0 | Disposed | 5506 | Direct |
| 2024-11-29 | Common Stock | M | 188 | $208.9 | Acquired | 5694 | Direct |
| 2024-11-29 | Common Stock | S | 188 | $539.0 | Disposed | 5506 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-11-29 | Non-Qualified Stock Option (right to buy) | $208.9 | M | 188 | Disposed | 2029-08-28 | Common Stock (188) | Direct |
| 2024-11-29 | Non-Qualified Stock Option (right to buy) | $290.33 | M | 188 | Disposed | 2029-02-28 | Common Stock (188) | Direct |
Footnotes
F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024.
F2: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.
F3: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.
More from INTUITIVE SURGICAL INC
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 21
Interim / Quarterly Report
2026
Apr 22
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3